Total planned funding: $1,762,639,479
Clear active filters
Treatment
HTXD: Treatment: ARV Drugs
Private Contractor
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $388,909,878 |
Tanzania | $305,266,106 |
Zambia | $274,346,819 |
Mozambique | $166,137,669 |
Zimbabwe | $103,720,779 |
Uganda | $83,554,231 |
Côte d'Ivoire | $80,672,993 |
Rwanda | $78,829,782 |
Haiti | $62,048,763 |
Vietnam | $50,696,593 |
Democratic Republic of the Congo | $38,992,187 |
Ethiopia | $34,562,102 |
Kenya | $32,529,278 |
South Africa | $14,132,678 |
Eswatini | $13,233,454 |
Ukraine | $11,538,171 |
Cameroon | $10,136,747 |
Guyana | $3,890,000 |
Botswana | $3,019,395 |
Namibia | $2,958,695 |
South Sudan | $2,005,850 |
Burundi | $1,457,309 |
Malawi | $0 |
Lesotho | $0 |
Organizational Types
Private Contractor | $1,762,639,479 |
Program Areas
Treatment | $1,762,639,479 |
Budget Codes
HTXD: Treatment: ARV Drugs | $1,762,639,479 |
Top Partner Programs
Chemonics International:
$1,059,495,183
View countries